Cherney DZI, de Zeeuw D, Heerspink HJL, Cardona J, et al. Safety, tolerability, pharmacodynamics and pharmacokinetics of the soluble guanylyl cyclase activator BI 685509 in patients with diabetic kidney disease: A randomized trial. Diabetes Obes Metab 2023 May 25. doi: 10.1111/dom.15099.
PMID: 37232058